Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Non-instrumental biofeedback for fecal incontinence and constipation issues

Official title: Tratamiento de la Incontinencia Fecal y Los Trastornos Funcionales de la defecación Mediante Biofeedback no Instrumental

Run by Hospital Universitari Vall d'Hebron Research Institute · NCT06273046 · Data updated 2026-11-12

This study is testing if non-instrumental biofeedback techniques can help people with fecal incontinence and constipation feel better compared to a placebo.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment96 (estimated)
SponsorHospital Universitari Vall d'Hebron Research Institute
Academic / other
Drugs / interventionsradiation
Locations1 site (Barcelona)
StatusRecruiting
StartedApril 17, 2024
Main results expectedApril 30, 2026
Study endsAugust 30, 2026
Registry record updatedJune 15, 2026
Trial IDNCT06273046 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients experiencing fecal incontinence with at least four episodes in the last two weeks or those with constipation characterized by less than three bowel movements per week.

Probably not a fit

Patients with organic digestive diseases, neurological disorders, or a history of certain colorectal conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of non-instrumental biofeedback techniques in treating fecal incontinence and functional defecation disorders. It involves cognitive interventions using audiovisual programs designed specifically for managing anorectal functional disorders. Patients will be divided into two groups based on their condition: those with fecal incontinence and those with dyssynergic defecation. The study will assess the efficacy of these techniques compared to a placebo.

Why it matters

Potential benefit: If successful, this approach could provide a less invasive and more cost-effective treatment option for patients suffering from fecal incontinence and constipation.

How similar studies have gone: While instrumental biofeedback has been established, this non-instrumental approach is relatively novel and has not been extensively tested in similar studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Incontinence studies

* Patients who have at least 4 episodes of fecal incontinence during the last 14 days.
* Patients able to follow instructions and attend study visits.

Dyssinergic defecation studies

* Patients with constipation who present less than 3 complete spontaneous bowel movements per week and/or who have Bristol 1 or Bristol 2 type stools in more than 25% of the bowel movements in the 2 weeks prior to the study
* Patients able to follow instructions and attend study visits.

Exclusion Criteria:

* Patients with organic digestive diseases such as inflammatory bowel disease, celiac disease, gastro-duodenal ulcer...
* Patients with neurological diseases (spinal cord injury, multiple sclerosis, Parkinson's disease).
* Patients with previous of active colon and/or rectal cancer.
* Patients with rectal fistula.
* Patients with rectal prolapse.
* Patients with total colectomy.
* Patients who have had any radiation to the pelvis in the last month.

Where it's running

  • Hospital Vall d'Hebron
    Barcelona, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.